SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination

In Denmark, vaccination against Severe Acute Respiratory Syndrome Corona Virus 2 (SARS‐CoV‐2) has been with the Pfizer‐BioNTech (BTN162b2) or the Moderna (mRNA‐1273) mRNA vaccines. Patients with chronic hepatitis C virus (HCV) infection followed in our clinic received mRNA vaccinations according to...

Full description

Saved in:

Bibliographic Details
Published in:	APMIS : acta pathologica, microbiologica et immunologica Scandinavica microbiologica et immunologica Scandinavica, 2023-03, Vol.131 (3), p.128-132
Main Authors:	Castruita, Jose Alfredo Samaniego, Schneider, Uffe Vest, Mollerup, Sarah, Leineweber, Thomas Daell, Weis, Nina, Bukh, Jens, Pedersen, Martin Schou, Westh, Henrik
Format:	Article
Language:	English
Subjects:	Antibodies, Viral blood COVID-19 - prevention & control COVID-19 Vaccines Hepacivirus Hepatitis C Hepatitis C virus Hepatitis C, Chronic Humans mRNA SARS-CoV-2 - genetics SARS‐CoV‐2 Short Communications Vaccination vaccine
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!